Skip to search formSkip to main contentSkip to account menu

PHA 793887

Known as: PHA-793887, PHA793887 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Cyclin-dependent kinase (CDK) inhibitors have been considered as excellent drug candidates for cancer therapy owing to their… 
2009
2009
AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO PHA-793887 is a potent inhibitor of the kinase activity of CDK2, CDK1, CDK4…